Logistic Properties of the Americas(LPA) - 2025 Q3 - Earnings Call Presentation
2025-11-13 14:00
Logistic Properties of the Americas Third Quarter 2025 Supplemental Information LPA Parque Logístico Calle 80 – Bogota, Colombia LPA Parque Logístico San José Verbena –San Jose, Costa Rica LPA Parque Logístico Calle 80 – Bogota, Colombia Disclaimer This presentation (the "Presentation") is provided for informational purposes only and has been prepared to provide interested parties with certain information about Logistic Properties of the Americas and its subsidiaries (collectively, "LPA") and for no other p ...
Chicago Atlantic BDC, Inc.(LIEN) - 2025 Q3 - Earnings Call Presentation
2025-11-13 14:00
Company Overview - Chicago Atlantic BDC has closed over $3.2 billion in loans since its platform inception[10] - The company's total portfolio investment value is $311 million[10] - The gross weighted-average yield of the company's debt investments is 15.8%[10] - 100% of the company's current debt investments are senior secured[10] Financial Performance - Gross investment income for the quarter ended September 30, 2025, was $15.1 million[24] - Net investment income for the same quarter was $9.5 million, or $0.42 per share[24] - Net asset value at the end of the period was $302.9 million, or $13.27 per share[24] Portfolio Composition and Strategy - 76% of the investment portfolio is allocated to cannabis-related businesses, while 24% is in non-cannabis sectors[29] - 71% of the debt portfolio is protected from further interest rate declines due to fixed rates or rate floors[15, 42] - Internally agented deals account for 83.8% of the portfolio companies[27]
Ardent Health Partners, Inc.(ARDT) - 2025 Q3 - Earnings Call Presentation
2025-11-13 14:00
3Q25 Performance - Total revenue increased by 8.8% to $1.577 billion in 3Q25[14] - Adjusted EBITDA grew by 46.3% to $143 million in 3Q25[14] - Adjusted EBITDA margin expanded by 240 bps to 9.1% in 3Q25[14] - Operating cash flow increased by 72.1% to $154 million in 3Q25[14] Year-to-Date (YTD) Performance - Total revenue increased by 8.2% to $4.719 billion YTD[14] - Adjusted EBITDA increased by 30.1% to $411 million YTD[14] - Adjusted EBITDA margin expanded by 150 bps to 8.7% YTD[14] - Operating cash flow increased by 26.4% to $247 million YTD[14] Volume and Revenue Drivers - Admissions increased by 5.8% in 3Q25 and 6.7% YTD[12] - Adjusted admissions increased by 2.9% in 3Q25 and 2.4% YTD[12] - Net patient service revenue per adjusted admission grew by 5.8% to $17,252 in 3Q25[14] Full-Year 2025 Guidance - Total revenue guidance reaffirmed at $6.2 billion to $6.45 billion[25] - Adjusted EBITDA guidance revised to $530 million to $555 million[25] - Adjusted admissions growth expected to be between 2.0% and 3.0%[25]
Nexxen International(NEXN) - 2025 Q3 - Earnings Call Presentation
2025-11-13 14:00
Financial Performance - Q3 2025 Contribution ex-TAC increased by 8% year-over-year, with programmatic revenue up by 10% year-over-year[18] - Excluding political contributions, Contribution ex-TAC grew by 14% and programmatic revenue grew by 15%[18] - CTV revenue reached $24.5 million in Q3 2025[18] - Adjusted EBITDA for Q3 2025 was $28.2 million, representing a 30% Adjusted EBITDA Margin[18] - Q3 2025 Non-IFRS Diluted EPS was $0.20[19] Liquidity and Capital Allocation - Net cash from operating activities in Q3 2025 was $35.8 million[19] - Cash and cash equivalents totaled $116.7 million as of September 30, 2025[19,20] - The company has $50 million undrawn on its revolving credit facility with no long-term debt[19] - Approximately 1.8 million shares were repurchased in Q3 2025, completing a $50 million share repurchase program and launching a new $20 million program[22] - The company invested an additional $20 million in VIDAA, with $15 million to be invested in Q3 2026[22] Future Outlook - The company updated its full year 2025 guidance, projecting Contribution ex-TAC between $350 million and $360 million and Adjusted EBITDA between $113 million and $117 million[24] - Programmatic revenue is expected to represent 95% of full year 2025 revenue[24]
Lantern Pharma(LTRN) - 2025 Q3 - Earnings Call Presentation
2025-11-13 14:00
Third Quarter 2025 Operating & Financial Results Conference Call / Webinar Nov 13th, 2025 9AM Eastern Time NASDAQ :LTRN Forward Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, among other things, statements relating to: future events or our future financial performance; the potential advantages of o ...
Fidelis Insurance (FIHL) - 2025 Q3 - Earnings Call Presentation
2025-11-13 14:00
Financial Performance - The company's Q3 2025 combined ratio was 790%, the best as a publicly traded company to date[14] - The annualized Operating ROAE was 214% for Q3 2025[14, 15] - Book value per diluted common share grew to $2329[14, 19] - Gross premiums written for the trailing twelve months ended September 30, 2025 were $47 billion[7, 8] Growth and Premiums - Gross premiums written grew by 8% in Q3 2025 compared to Q3 2024, reaching $798 million[15, 18] - Year-to-date gross premiums written increased by 8% or $290 million, totaling $3739 million[19, 20] - Insurance gross premiums written increased by 6% year-to-date, reaching $2775 million[23, 25] - Reinsurance gross premiums written increased by 16% year-to-date[27, 30] Capital Management - The company returned $180 million of capital to common shareholders in the nine months ended September 30, 2025, including $143 million in share repurchases and $37 million in dividends[20] - The company has $1531 million remaining for share repurchase authorization[37] Investment Portfolio - Net investment income for Q3 2025 was $46 million, bringing the year-to-date total to $140 million[15, 36]
Distribution Solutions Group (NasdaqGS:DSGR) FY Earnings Call Presentation
2025-11-13 13:55
Powerful Solutions. Proven Results. NASDAQ: DSGR Baird Global Industrial Conference November 13, 2025 Disclaimers Cautionary Note Regarding Forward-Looking Statements This presentation contains certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the "safe-harbor" provisions under the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. The terms ...
Hydrofarm(HYFM) - 2025 Q3 - Earnings Call Presentation
2025-11-13 13:30
Forward-Looking Statements. This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to known and unknown risks, uncertainties and other important factors that may cause actual results to be materially different from the statements made herein. All statements other than statements of historical fact included in this presentation are forward-looking statements, including, but not limited to, the Company's financial re ...
Stratasys(SSYS) - 2025 Q3 - Earnings Call Presentation
2025-11-13 13:30
Q3 2025 Financial Results - Q3 2025 revenue reached $137 million[32, 34, 58], a decrease of 2.1% compared to Q3 2024[58] - GAAP gross profit was $56.1 million[58], with a margin of 41.0%[38, 58], while non-GAAP gross profit was $62.1 million[58], with a margin of 45.3%[38, 58] - GAAP operating loss was $22.7 million[44, 58], representing a -16.6% margin[58], while non-GAAP operating income was $0.1 million[44, 58], representing a 0.1% margin[44, 58] - GAAP net loss was $55.6 million[44, 58], or -$0.65 diluted EPS[44, 58], which includes a non-cash impairment charge of $33.9 million related to Ultimaker investment[44], while non-GAAP net income was $1.5 million[44, 58], or $0.02 diluted EPS[44, 58] - Adjusted EBITDA was $5.0 million[44, 61], representing 3.6% of total revenue[44] - Cash and cash equivalents and short-term deposits totaled $255 million[47, 49] Operational Highlights - Disciplined cost management led to a 440bp reduction in adjusted OpEx[30], contributing to solid OCF and EPS[12, 30] - The company is focused on operational excellence, partnerships, and strategy execution to advance additive innovation[12] - Noteworthy purchases from Honeywell, TE Connectivity and L3Harris in the defense sector[16] - A leading social media, AI, VR/AR company purchased four F3300 FDM systems for large-scale prototyping and production parts[19, 23] 2025 Full-Year Outlook - The company projects full-year revenue between $550 million and $560 million[52] - Non-GAAP gross margins are expected to be between 46.7% and 47.0%[52] - Non-GAAP operating expenses are projected to be between $248 million and $251 million[52]
Bausch + Lomb (NYSE:BLCO) 2025 Earnings Call Presentation
2025-11-13 13:30
INVESTOR DAY November 13th, 2025 Disclaimers Forward-Looking Statements This presentation contains forward-looking information and statements, within the meaning of applicable securities laws (collectively, "forward-looking statements"), including, but not limited to, statements regarding future prospects and performance of Bausch + Lomb Corporation ("Bausch + Lomb", the "Company", "we", "us", or "B+L"), our 2025 full year guidance, our three year financial targets (including targets for Company and segment ...